By the end of this period, the global market is forecast to reach a valuation of USD 7.61 billion. Venous ulcers, often caused by chronic venous insufficiency, represent a significant portion of ...
(Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will be initiating a controlled, multicenter Phase II clinical study evaluating ...